US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist

13.440
+0.810+6.41%

Close Feb 14 16:00 ET

13.230
-0.210-1.56%

Pre 04:27 ET

502.92MMarket Cap9.33P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entrada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 11.950M	--
--	2024/Q4	-- / 12.923M	--
--	2024/Q3	19.570M / 11.875M	--
--	2024/Q2	94.694M / 36.433M	--
--	2024/Q1	59.120M / 15.195M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 11.950M--

--2024/Q4-- / 12.923M--

--2024/Q319.570M / 11.875M--

--2024/Q294.694M / 36.433M--

--2024/Q159.120M / 15.195M--

Unlock Free Earnings Estimates

Open Account

Entrada Therapeutics Earnings Reports

Entrada Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 07:16 ET

Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Third Quarter 2024 Financial Results

Nov 5, 2024 07:11 ET

Entrada Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13, 2024 07:17 ET

Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Second Quarter 2024 Financial Results

Aug 13, 2024 07:07 ET